STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say

The FDA used the president’s budget to propose policies aimed at encouraging domestic development and manufacturing of drugs

$35 insulin, more evidence abortion meds are safe OTC, and other health news from Morning Rounds

Gilead is buying the German biotech Tubulis for more than $3 billion, a move that will expand its oncology pipeline.

The researchers identified a driving force behind the condition, opening up a potential target for new therapies.